Projects per year
Personal profile
External positions
Fingerprint Dive into the research topics where Luca Vangelista is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Immunoglobulin E
Medicine & Life Sciences
Allergens
Medicine & Life Sciences
Pollen
Medicine & Life Sciences
Phleum
Medicine & Life Sciences
Betula
Medicine & Life Sciences
Chemokine CCL5
Medicine & Life Sciences
Hypersensitivity
Medicine & Life Sciences
HIV-1
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Projects 2018 2020
- 2 Active
Development of a CCL5-based lead compound for Staphylococcus aureus infection inhibition
4/6/18 → 12/31/20
Project: Research project
Staphylococcus aureus
Infection
Anti-Bacterial Agents
Dendritic Cells
HIV-1
Periostin in inflammatory bowel disease (IBD) development and synergistic effects mediated via CCL5 and MMP9.
Riethmacher, D., Riethmacher, E., Vangelista, L., Ashimkhanova, A., Adrisova, K., Kuatbai, G., Kim , A. K. & Ainur Abdrakhmanova, A.
3/20/18 → 12/31/20
Project: Research project
Kazakhstan
Inflammatory Bowel Diseases
Communication
Physicians
Incidence
Research Output 1996 2019
AllergoOncology: Microbiota in allergy and cancer—A European Academy for Allergy and Clinical Immunology position paper
Untersmayr, E., Bax, H. J., Bergmann, C., Bianchini, R., Cozen, W., Gould, H. J., Hartmann, K., Josephs, D. H., Levi-Schaffer, F., Penichet, M. L., O'Mahony, L., Poli, A., Redegeld, F. A., Roth-Walter, F., Turner, M. C., Vangelista, L., Karagiannis, S. N. & Jensen-Jarolim, E., Jan 1 2019, In : Allergy: European Journal of Allergy and Clinical Immunology.Research output: Contribution to journal › Article
Open Access
Microbiota
Allergy and Immunology
Hypersensitivity
Immune Tolerance
Immunity
8
Citations
(Scopus)
AllergoOncology: Opposite outcomes of immune tolerance in allergy and cancer
Jensen-Jarolim, E., Bax, H. J., Bianchini, R., Crescioli, S., Daniels-Wells, T. R., Dombrowicz, D., Fiebiger, E., Gould, H. J., Irshad, S., Janda, J., Josephs, D. H., Levi-Schaffer, F., O’Mahony, L., Pellizzari, G., Penichet, M. L., Redegeld, F., Roth-Walter, F., Singer, J., Untersmayr, E., Vangelista, L. & 1 others, , Feb 1 2018, In : Allergy: European Journal of Allergy and Clinical Immunology. 73, 2, p. 328-340 13 p.Research output: Contribution to journal › Article
Open Access
Immune Tolerance
Hypersensitivity
Neoplasms
Tumor Escape
Immunologic Desensitization
1
Citation
(Scopus)
Rational CCL5 mutagenesis integration in a lactobacilli platform generates extremely potent HIV-1 blockers
Secchi, M., Grampa, V. & Vangelista, L., Dec 1 2018, In : Scientific Reports. 8, 1, 1890.Research output: Contribution to journal › Article
Lactobacillus
Mutagenesis
HIV-1
HIV Fusion Inhibitors
Anti-Infective Agents
7
Citations
(Scopus)
The expanding therapeutic perspective of CCR5 blockade
Vangelista, L. & Vento, S., Jan 12 2018, In : Frontiers in Immunology. 8, JAN, 1981.Research output: Contribution to journal › Short survey
Open Access
HIV-1
Chemokines
Pathology
Ligands
Gene Knockout Techniques
23
Citations
(Scopus)
AllergoOncology – the impact of allergy in oncology: EAACI position paper
Jensen-Jarolim, E., Bax, H. J., Bianchini, R., Capron, M., Corrigan, C., Castells, M., Dombrowicz, D., Daniels-Wells, T. R., Fazekas, J., Fiebiger, E., Gatault, S., Gould, H. J., Janda, J., Josephs, D. H., Karagiannis, P., Levi-Schaffer, F., Meshcheryakova, A., Mechtcheriakova, D., Mekori, Y., Mungenast, F. & 12 others, , Jun 1 2017, In : Allergy: European Journal of Allergy and Clinical Immunology. 72, 6, p. 866-887 22 p.Research output: Contribution to journal › Article
Hypersensitivity
Immunoglobulin E
Neoplasms
Antibodies
Cross-Priming